Correlation
The correlation between GPCR and AZN is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
GPCR vs. AZN
Compare and contrast key facts about Structure Therapeutics Inc. American Depositary Shares (GPCR) and AstraZeneca PLC (AZN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GPCR or AZN.
Performance
GPCR vs. AZN - Performance Comparison
Loading data...
Key characteristics
GPCR:
-0.39
AZN:
-0.14
GPCR:
-0.29
AZN:
-0.02
GPCR:
0.97
AZN:
1.00
GPCR:
-0.51
AZN:
-0.11
GPCR:
-0.92
AZN:
-0.19
GPCR:
45.06%
AZN:
16.17%
GPCR:
91.89%
AZN:
23.19%
GPCR:
-80.96%
AZN:
-48.94%
GPCR:
-70.71%
AZN:
-15.72%
Fundamentals
GPCR:
$1.25B
AZN:
$225.80B
GPCR:
-$2.58
AZN:
$2.48
GPCR:
0.00
AZN:
4.11
GPCR:
1.52
AZN:
5.50
GPCR:
$0.00
AZN:
$54.98B
GPCR:
-$231.74K
AZN:
$44.75B
GPCR:
-$181.48M
AZN:
$17.70B
Returns By Period
In the year-to-date period, GPCR achieves a -19.76% return, which is significantly lower than AZN's 12.71% return.
GPCR
-19.76%
-20.38%
-34.36%
-36.37%
N/A
N/A
N/A
AZN
12.71%
3.29%
9.21%
-4.76%
5.29%
8.39%
11.48%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GPCR vs. AZN — Risk-Adjusted Performance Rank
GPCR
AZN
GPCR vs. AZN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Structure Therapeutics Inc. American Depositary Shares (GPCR) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GPCR vs. AZN - Dividend Comparison
GPCR has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 2.10%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GPCR Structure Therapeutics Inc. American Depositary Shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 2.10% | 2.27% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% |
Drawdowns
GPCR vs. AZN - Drawdown Comparison
The maximum GPCR drawdown since its inception was -80.96%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for GPCR and AZN.
Loading data...
Volatility
GPCR vs. AZN - Volatility Comparison
Structure Therapeutics Inc. American Depositary Shares (GPCR) has a higher volatility of 15.22% compared to AstraZeneca PLC (AZN) at 8.32%. This indicates that GPCR's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GPCR vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Structure Therapeutics Inc. American Depositary Shares and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities